Synchrotron radiation therapyCancer is a worldwide issue, in 2012 alone, 14.1 million cases were diagnosed, 8.2 million people died and 32.5 million people were left living with cancer. Without new therapies the numbers are projected to rise significantly by 2030.

Following decades of development in particle physics labs, the use of beams of protons or ions to precise target and kill tumours is beginning to transform the global cancer therapy scene.

Recently Resolve Optics supplied custom designed radiation resistant lenses that form key targeting optical elements in synchrotron radiation therapy machines being supplied to help beat the cancer epidemic.

The status of proton beam therapy article (in full in Jan/Feb 2018 issue) … click here

More about Resolve Optics radiation resistant lenses … click here

Share this: